These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver. Fiorucci S; Antonelli E; Morelli A Dig Liver Dis; 2003 May; 35 Suppl 2():S61-9. PubMed ID: 12846445 [TBL] [Abstract][Full Text] [Related]
8. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. Bosch J; Abraldes JG; Fernández M; García-Pagán JC J Hepatol; 2010 Sep; 53(3):558-67. PubMed ID: 20561700 [TBL] [Abstract][Full Text] [Related]
9. Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. Fiorucci S; Antonelli E; Tocchetti P; Morelli A Cardiovasc Drug Rev; 2004; 22(2):135-46. PubMed ID: 15179450 [TBL] [Abstract][Full Text] [Related]
10. Statins and portal hypertension: a new pharmacological challenge. Ramírez G; Briceño J; Rojas A Curr Vasc Pharmacol; 2012 Nov; 10(6):767-72. PubMed ID: 22272892 [TBL] [Abstract][Full Text] [Related]
11. [The application of non-selective β-blockers, angiotensin receptor antagonists and statins in liver cirrhotic patients]. Zhang XX; Guo JS Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):923-928. PubMed ID: 31941254 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacological modulation of portal hypertension syndrome: current status and future prospects]. González García M; Albillos Martínez A Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():1-7. PubMed ID: 15195528 [No Abstract] [Full Text] [Related]
13. Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats. Hsu SJ; Wang SS; Hsin IF; Huang HC; Lee FY; Lee JY; Lin HC; Chuang CL; Lee SD Scand J Gastroenterol; 2013 Jul; 48(7):831-8. PubMed ID: 23672611 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamics in the isolated cirrhotic liver. Zipprich A J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473 [TBL] [Abstract][Full Text] [Related]
15. [Treatment update on portal hypertension and complications]. Lee JW Korean J Gastroenterol; 2010 Sep; 56(3):144-54. PubMed ID: 20847605 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of portal hypertension. Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641 [TBL] [Abstract][Full Text] [Related]
17. New cellular and molecular targets for the treatment of portal hypertension. Gracia-Sancho J; Maeso-Díaz R; Fernández-Iglesias A; Navarro-Zornoza M; Bosch J Hepatol Int; 2015 Apr; 9(2):183-91. PubMed ID: 25788198 [TBL] [Abstract][Full Text] [Related]